Lumida
/CHD
⌘K
Church & Dwight Co Inc

Church & Dwight Co Inc

CHD
$94.15USD+0.22%+0.21 today

MARKET CAP

22.3B

P/E (TTM)

26.8x

FWD P/E

23.8x

DAY RANGE

$93 – $95

52W RANGE

$81
$106

AI Summary

Stalk
TrimMedium

CHD’s decisive breach of the 200-day SMA and active Stage 3 distribution confirm a medium-term bearish stance. However, the Bearish Exhaustion reversal candle amid extreme oversold conditions signals seller fatigue and the potential for a bounce. Price remains below key EMAs with no reclaim attempt, so execution should be deferred until bearish momentum reasserts near moving averages or structural resistance.

  • Q2 2026 organic sales rose 5.8% vs 3% forecast driven by volume gains
  • New products to account for ~50% of organic growth; TheraBreath outperformed
  • Gross margins set to contract ~60 bps from input‐cost inflation and tariffs
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$5.2B$5.4B$5.9B$6.1B$6.2B
YoY %+6.0%+3.6%+9.2%+4.1%+1.6%
P / Sales4.9x3.8x4.0x4.2x3.3x
EV / Sales5.8x4.6x4.7x4.8x4.0x
Gross Profit, Adj.$2.3B$2.3B$2.6B$2.8B$2.8B
YoY %+2.2%-0.6%+15.0%+7.8%-0.5%
Margin %43.6%41.9%44.1%45.7%44.7%
EV / Gross Profit13.3x11.0x10.7x10.5x9.0x
EBITDA, Adj.$1.3B$1.2B$1.3B$1.4B$1.3B
YoY %+6.5%-5.4%+4.5%+9.4%-5.6%
Margin %25.0%22.8%21.9%23.0%21.4%
EV / EBITDA23.2x20.2x21.7x21.0x18.9x
EBIT$1.1B$597.8M$1.1B$1.2B$1.1B
YoY %+4.8%-44.6%+76.9%+10.1%-7.4%
Margin %20.8%11.1%18.0%19.1%17.4%
EV / EBIT27.9x41.5x26.3x25.3x23.2x
Net Income$827.5M$413.9M$755.6M$585.3M$736.8M
YoY %+5.3%-50.0%+82.6%-22.5%+25.9%
Net Margin15.9%7.7%12.9%9.6%11.9%
EPS (GAAP)$3.32$1.68$3.05$2.37$3.02
YoY %+6.4%-49.4%+81.5%-22.3%+27.4%